North America Analysis
Home Search

COVID-19 - search results

If you're not happy with the results, please do another search
covid-19 hospitalisations

Fluvoxamine can cut COVID-19 hospitalisations by 30%

Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.
COVID-19 booster

Are you eligible for the COVID-19 booster jab?

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.
Back to Health

Back to Health campaign to help one million recover from COVID-19

Helpforce launches new Back to Health campaign to support the health and care sector as it recovers from COVID-19 and battles through winter pressures.
COVID-19 antibody response

Third of leukaemia patients show no COVID-19 antibody response

According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.
risk of pregnancy loss

Risk of pregnancy loss not associated with COVID-19 vaccines

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.
COVID-19 cure

COVID-19 cure fraud: How far can the law go in judging religious beliefs?

The prosecution of a bishop for selling a supposed COVID-19 cure raises questions about how far the can law go in judging religious beliefs. John Binns and Suzanne Gallagher of BCL Solicitors LLP investigate.
apprenticeships and training

How COVID-19 is changing perceptions on apprenticeships and training

Jackie Denyer, MD and Founder, Professional Training Solutions, discusses why attitudes towards apprenticeships and training need to change after organisations realised that the UK workforce is ill-equipped to handle shortages, during the pandemic.
mental health COVID-19

Mental health in light of the COVID-19 pandemic

Dr Hans Henri P. Kluge, Regional Director & Dr Natasha Azzopardi-Muscat, Director of Country Health Policies and Systems at WHO/Europe, lift the lid on mental health in light of the COVID-19 pandemic.
clinical backlog

Tackling the clinical backlog consequences of COVID-19

Keith Davies and Prof Dr Harald Braun of i5 Health & Analytics explain tackling the clinical backlog consequences of COVID-19.
covid-19 emerging markets

The challenge of COVID-19 for emerging markets

Adam Heuman, Vice-President Global Development and Communication, EMpower – The Emerging Markets Foundation, sheds light on the challenge of COVID-19 for emerging markets.
the covid-19 vaccines

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
COVID-19 in African countries

Impact of COVID-19 in African countries

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.
antibody levels

COVID-19: Antibody levels for the double-jabbed are waning

Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.
organ transplants

Organ transplants fell by a third during first wave of COVID-19

Organ transplants performed during the first wave of COVID-19 fell by a third compared to 2019, according to a new study.
COVID-19 vaccine responses

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
third COVID-19 vaccine

Clinical trial to test third COVID-19 vaccine for people with weakened immune systems

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.
mental health in the

Has COVID-19 made mental health at work impossible to ignore?

Jorge E Palacios, MD, PhD, Senior Digital Health Scientist at SilverCloud Health, argues that the pandemic has made mental health in the workplace impossible to ignore.
vaccination logistics

COVID-19: Challenges of vaccination logistics

The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.
enablers of food security

COVID-19: Protecting the invisible enablers of food security

Frances Goodrum, Head of External Affairs, Brooke Action for Working Horses and Donkeys, walks us through why we need to protect the invisible enablers of food security in light of COVID-19.
antibody treatments

Campaigners call for approval of life saving COVID-19 antibody treatments

A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

Follow Open Access Government